Infectious diseases (London, England)最新文献

{"title":"Comparison of clinical characteristics and outcomes in hospitalized adult patients infected with respiratory syncytial virus and influenza virus.","authors":"Sun Hee Na, Hyeon Jae Jo, Jin Ju Park, Yubin Seo, Jacob Lee, Jiyeon Bae, Minkyeong Lee, Chan Mi Lee, Chang Kyung Kang, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim","doi":"10.1080/23744235.2024.2402914","DOIUrl":"10.1080/23744235.2024.2402914","url":null,"abstract":"<p><strong>Background: </strong>Because patients infected with respiratory syncytial virus (RSV) have been reported to be older than patients infected with influenza virus, the more frequent incidence of complications in RSV-infected patients may be age-related. This study compared clinical characteristics and outcomes in hospitalized adults infected with RSV with findings in age- and sex-matched adults infected with influenza virus.</p><p><strong>Methods: </strong>The medical records of hospitalized adult patients infected with RSV or influenza virus at two university hospitals from 2013 to 2022 were retrospectively analyzed. Virus infection was confirmed by real-time polymerase chain reaction. Each RSV-infected patient was matched by age and sex with two influenza virus-infected patients, and their clinical symptoms, laboratory parameters and hospital courses were compared.</p><p><strong>Results: </strong>The study cohort consisted of 552 patients, 184 infected with RSV and 368 infected with influenza virus. Fever (71.2% vs. 79.9%, <i>p</i> = .022) and cough (70.1% vs. 80.4%, <i>p</i> = .007) were significantly less frequent in the RSV than in the influenza group, whereas white blood cell counts (9132/mm³ vs. 7616/mm³, <i>p</i> < .001) and C-reactive protein concentrations (10.25 vs. 8.88 mg/dL, <i>p</i> = .029) were significantly higher in the RSV group. The frequency of oxygen therapy was higher (60.3% vs. 48.6%, <i>p</i> = .010) and hospital stay was longer (8 vs. 6 days, <i>p</i> = .003) in RSV than in influenza virus-infected patients.</p><p><strong>Conclusions: </strong>Clinical symptoms were less frequent, but disease was more severe, in hospitalized adult patients infected with RSV than in age- and sex-matched patients infected with influenza. Greater attention should be paid to diagnosing and preventing RSV infection in adults.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"159-166"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pertussis epidemic in Korea and implications for epidemic control.","authors":"Joowon Lee","doi":"10.1080/23744235.2024.2441894","DOIUrl":"10.1080/23744235.2024.2441894","url":null,"abstract":"<p><p>The pertussis epidemic in Korea is ongoing, with a record-high incidence rate. Although pertussis incidence is high worldwide in 2024, the scale of the increase observed in Korea is unprecedented and incomparable to that in other countries. The high proportion of cases among children aged 5 to 14 years is the distinctive characteristics of the 2024 pertussis epidemic in Korea. To accurately interpret the epidemiological trend in pertussis incidence in Korea, validating the surveillance system and evaluating vaccine efficacy and effectiveness are essential.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"207-210"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142831018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The silent spread: why we need increased awareness of Crimean-Congo haemorrhagic fever.","authors":"Parminder Singh, Shubham Kumar, Ashok Kumar Balaraman, Rachana Mehta, Sanjit Sah","doi":"10.1080/23744235.2024.2420253","DOIUrl":"10.1080/23744235.2024.2420253","url":null,"abstract":"<p><p>Crimean-Congo Hemorrhagic Fever (CCHF) presents significant global health challenges, highlighted by its sporadic nature and high fatality rates. The manuscript emphasizes the disease's tendency to be under-recognized and the diagnostic challenges it poses, often mimicking other illnesses and leading to frequent misdiagnosis. There is a noted absence of robust diagnostic tools, specific treatments, or vaccines, leaving only supportive care generally available. The necessity for increased international cooperation and a coordinated strategy to enhance disease surveillance, public health preparedness, and community education is stressed.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"100-102"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Urgent need for sustainable behavioral change interventions for effective control of rabies.","authors":"Francesco Branda, Krishna Prasad Acharya, Giancarlo Ceccarelli, Massimo Ciccozzi, Fabio Scarpa, Kailash Bohara, Jiyeon Oh, Dong Keon Yon","doi":"10.1080/23744235.2024.2423243","DOIUrl":"10.1080/23744235.2024.2423243","url":null,"abstract":"","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"112-116"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and risk factors for haematogenous periprosthetic joint infection during <i>Staphylococcus aureus</i> bacteraemia.","authors":"Hanna Blank, Hebba Abdul Rahim, Olof Thompson, Lisa I Påhlman","doi":"10.1080/23744235.2024.2389482","DOIUrl":"10.1080/23744235.2024.2389482","url":null,"abstract":"<p><strong>Background: </strong><i>Staphylococcus aureus</i> bacteraemia (SAB) may lead to periprosthetic joint infections (PJI) <i>via</i> haematogenous spread of bacteria to the joint. Due to the risk of PJI, patients with SAB and prosthetic joint are recommended prolonged antibiotic treatment. The aim of the study was to assess the risk of PJI during SAB, and to evaluate if short treatment duration affects outcomes in patients with uncomplicated SAB and prosthetic joints without clinical signs of PJI.</p><p><strong>Methods: </strong>Patients with growth of <i>S. aureus</i> in blood cultures were cross-referenced against the Swedish Arthroplasty register to identify patients with prosthetic hip or knee joints at the time of SAB. Medical records were reviewed to identify PJI at the time of SAB and during a 6-month follow-up period.</p><p><strong>Results: </strong>Out of 400 patients with SAB and a prosthetic joint, 281 met all eligibility criteria and were included in the study. Of the included participants, 35 (12%) had a haematogenous PJI. Younger age and presence of multiple prosthetic joints were associated with an increased risk of PJI. Of the 247 patients without signs of PJI at the initial SAB episode, 118 patients (48%) had an uncomplicated infection and received short total antibiotic treatment (median 15 days, IQR 13-17). The risk of PJI during the follow-up period was low (<1%) and similar in the uncomplicated group compared to patients with complicated SAB that received longer antibiotic treatment (median 29 days, IQR 15-70).</p><p><strong>Conclusion: </strong>The prevalence of haematogenous PJI was lower than previously reported. Our data do not support prolonged antibiotic treatment in patients with SAB and prosthetic joints without clinical signs of PJI.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"49-55"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rising threat of <i>Vibrio vulnificus</i>: managing flesh-eating bacterial infections post-hurricane in Florida.","authors":"Shubham Kumar, Priyanka Mohapatra, Ashok Kumar Balaraman, Rachana Mehta, Sanjit Sah","doi":"10.1080/23744235.2024.2424485","DOIUrl":"10.1080/23744235.2024.2424485","url":null,"abstract":"","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"117-119"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Synergistic efficacy of ceftazidime/avibactam and aztreonam against carbapenemase-producing <i>Pseudomonas aeruginosa</i>: insights from the hollow-fiber infection model.","authors":"María M Montero, Sandra Domene-Ochoa, Núria Prim, Eliana Ferola, Carla López-Causapé, Daniel Echeverria, Mario F Ampuero Morisaki, Victoria Vega-Toribio, Luisa Sorlí, Sonia Luque, Eduardo Padilla, Antonio Oliver, Juan P Horcajada","doi":"10.1080/23744235.2024.2396882","DOIUrl":"10.1080/23744235.2024.2396882","url":null,"abstract":"<p><strong>Background: </strong>Combination therapy is an attractive therapeutic option for extensively drug-resistant (XDR) <i>Pseudomonas aeruginosa</i> infections. Existing data support the combination of aztreonam and ceftazidime/avibactam (CZA) against class serine-β-lactamase (SBL)- and metallo-β-lactamase (MBL) - producing <i>Enterobacterales.</i> However, data about that combination against SBL- and MBL-producing <i>P. aeruginosa</i> are scarce. The objective of the study was to assess the <i>in vitro</i> activity of CZA and aztreonam alone and in combination against SBL- and MBL-producing XDR <i>P. aeruginosa</i> isolates.</p><p><strong>Methods: </strong>The combination was analyzed by means of the hollow-fiber infection model in three selected carbapenemase-producing <i>P. aeruginosa</i> isolates that were representative of the three most common XDR<i>P. aeruginosa</i> high-risk clones (ST175, ST111, ST235) responsible for global nosocomial infection outbreaks.</p><p><strong>Results: </strong>The three isolates were nonsusceptible to CZA and nonsusceptible to aztreonam. In the dynamic hollow-fiber infection model, the combination of CZA plus aztreonam exerts a bactericidal effect on the isolates, regardless of their resistance mechanism and demonstrates synergistic interactions against three isolates, achieving a bacterial reduction of 5.07 log₁₀ CFU/ml, 5.2 log₁₀ CFU/ml and 4 log₁₀ CFU/ml, respectively.</p><p><strong>Conclusion: </strong>The combination of CZA and aztreonam significantly enhanced the <i>in vitro</i> efficacy against XDR <i>P. aeruginosa</i> isolates compared to each monotherapy. This improvement suggests that the combination could serve as a feasible treatment alternative for infections caused by carbapenemase-producing XDR <i>P. aeruginosa</i>, especially in scenarios where no other treatment options are available.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"81-88"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Urgent need for enhanced food safety protocols in fast-food supply chains: lessons from the recent multi-state <i>E. coli</i> outbreak.","authors":"Parminder Singh, Ashok Kumar Balaraman, Rachana Mehta, Sanjit Sah","doi":"10.1080/23744235.2024.2422519","DOIUrl":"10.1080/23744235.2024.2422519","url":null,"abstract":"<p><p>Recent events, including a multi-state <i>E. coli</i> outbreak linked to McDonald's, have exposed significant vulnerabilities within fast-food supply chains. These incidents highlight complex issues of traceability and accountability, exacerbated by the high demands of fast-food operations which can compromise safety protocols. This paper discusses potential solutions such as advanced tracking technologies, uniform safety standards, and enhanced inspections to improve food safety. The focus is on strengthening public health protection and maintaining consumer trust in the fast-food industry.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"109-111"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"National trends in pneumonia-related mortality in the United States, 1999-2019.","authors":"Connor P Bondarchuk, Benjamin Grobman, Arian Mansur, Christine Y Lu","doi":"10.1080/23744235.2024.2390180","DOIUrl":"10.1080/23744235.2024.2390180","url":null,"abstract":"<p><strong>Introduction: </strong>Pneumonia is one of the most common causes of hospital admissions in the United States and remains a major cause of death. However, less is known regarding the mortality burden from pneumonia in the United States and how this burden has changed over time.</p><p><strong>Methods: </strong>Death rates from causes related to pneumonia were determined using the CDC Wide-ranging Online Data for Epidemiologic Research (WONDER) data from 1999-2019. Pneumonia deaths were calculated for the overall population as well as for sociodemographic subgroups. We also analysed changes in death rates over time.</p><p><strong>Results: </strong>Overall, 2.1% of total US deaths during the period between 1999 and 2019 were due to pneumonia (2.6% in 1999 and 1.5% in 2019). Mortality declined over time for both men and women, and across most age cohorts, as well as all racial, urbanisation, and regional categories. Rates of pneumonia deaths were higher among males as compared to females (age-adjusted mortality rate ratio (AAMRR) = 1.35; 95% CI: 1.34-1.35). Compared to White Americans, Black Americans had the highest pneumonia-related mortality rates of any racial group (AAMRR = 1.11; 95% CI: 1.10-1.11).</p><p><strong>Conclusions: </strong>Rates of pneumonia-related death have decreased in the United States in recent decades. However, significant racial and gender disparities remain, indicating the need for more equitable care.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"56-65"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Polio outbreak in Pakistan: urgent need for strengthened localized eradication strategies.","authors":"Mahendra Singh, Ashok Kumar Balaraman, Rachana Mehta, Sanjit Sah","doi":"10.1080/23744235.2024.2422513","DOIUrl":"10.1080/23744235.2024.2422513","url":null,"abstract":"<p><p>The resurgence of polio in Pakistan, with 39 cases as of October 2024, threatens global eradication efforts. Despite progress, Pakistan remains one of two countries where poliovirus transmission persists, alongside Afghanistan. Key challenges include vaccine hesitancy, driven by misinformation and cultural misconceptions and ongoing violence against vaccination workers. While upcoming campaigns aim to vaccinate 45 million children, addressing these challenges requires more than immunisation drives. Strengthened community engagement, enhanced surveillance, and improved security for healthcare workers are critical. To meet the 2025 eradication goal, Pakistan must prioritise localised strategies to overcome barriers and ensure the sustainability of its eradication efforts.</p>","PeriodicalId":73372,"journal":{"name":"Infectious diseases (London, England)","volume":" ","pages":"106-108"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}